October 11, 2022
Digital Conference8:30AM EST // 1:30PM BST // 2:30PM CEST Michael BurnsPrincipal Scientist at Lhasa Limited, UKSpeaker
Profile
Michael joined Lhasa in 2015 to work on the Mirabilis project, aiding the research and curation of knowledge relevant to understanding the potential for purging of mutagenic impurities from drug substance syntheses. In 2017, he took over leadership of Mirabilis development and has since been working closely with leading members of the purge calculation community to develop Mirabilis and the purge concept, including more recently their impact on the ongoing nitrosamine challenges.
Agenda Sessions
Computational and Predictive Methods for Assisting with Risk Assessment during Drug Synthesis
, 12:40pmView Session